Jessica Chubak works to improve cancer diagnosis, treatment, control, and survivorship. She is the Group Health Research Institute (GHRI) principal investigator for the National Cancer Institute's Cancer Research Network. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Based on a personal interest in how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data.
Dr. Chubak joined GHRI in 2007, bringing expertise in epidemiologic methods, pharmaco-epidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand. Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the University of Washington School of Public Health. A member of the American Society of Preventive Oncology and the Society for Epidemiologic Research, she also serves as a peer reviewer for a dozen journals, including Journal of the National Cancer Institute, Journal of Oncology Practice, and the Journal of Clinical Epidemiology.
Epidemiology; colorectal cancer; medication use; survivorship; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Chronic illness management; translation of preventive care research into clinical practice
Cancer risk and use of common medications; pharmaceutical outcomes research; validation of pharmacy data resources
Green BB, Anderson ML, Chubak J, Baldwin LM, Tuzzio L, Catz S, Cole A, Vernon SW. Colorectal cancer screening rates increased after exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016;29(2):191-200. doi: 10.3122/jabfm.2016.02.150290. PubMed
Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016 Mar 4. pii: 0969141316630766. [Epub ahead of print]. PubMed
Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM. Time to colonoscopy after positive fecal blood test in four US healthcare systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb 3. [Epub ahead of print].Cancer Epidemiol Biomarkers Prev. 2016 Feb 3. [Epub ahead of print]. PubMed
Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. Statistical methods for estimating the cumulative risk of screening mammography outcomes. Cancer Epidemiol Biomarkers Prev. 2015 Dec 31. pii: cebp.0824.2015. [Epub ahead of print]. PubMed
Research shows innovative approach serves health care consumers over long term.
A study to help kids with cancer get time with pets begins field work, with encouragement from a GHRI interest group.
Read about it in Healthy Findings.
KING-5 TV, Aug 8, 2013